Blog

Aug 6, 2016

Aubrey de Grey Explains SENS Anti-Cancer Strategy and Lifespan.io Campaign at D.N.A. Conference

Posted by in categories: biotech/medical, life extension

Dr. Aubrey de Grey of the of the SENS Research Foundation explains the OncoSENS approach to curing ALT-Cancer, the corresponding crowdunding campaign (https://www.lifespan.io/campaigns/sens-control-alt-delete-cancer/), and how this is a vital part of overcoming the ill-effects of aging.

This presentation is part of the Designing New Advances conference held by the Institute of Exponential Sciences in the Netherlands, orchestrated by Demian Hoed, and Lotte Van Norte.

ALT-Cancer refers to those cancers which use the Alternative Lengthening of Telomeres mechanism to attain cellular immortality, as opposed to the expression of the enzyme Telomerase.

Read more

Comments are closed.